🔗 Share this article

An underground economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Investigational Drug Gaining Traction Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Viewers are encouraged to contact these accounts privately for supplier links, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where groups with numerous of participants share “before and after” images, administration instructions and claims of next-day British shipping. Vendors promote the substance there before redirecting buyers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Voice Worries

However, physicians and pharmacists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting products of unknown origin.

Some experts stated the demand for the experimental drug could be connected to the rising cost of approved weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for human use under the British medical regulations.

Several influencers attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and consumer laws, potentially leading to penalties, legal action or imprisonment.

Platform Response and Material Elimination

Based on TikTok, the platform has removed violative content and banned related hashtags and query recommendations. The organization said it was dedicated to keeping the service secure and investing in strengthening compliance measures.

Online Marketplace Activities

Investigations also found communities with up to nine thousand participants marketing retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, filled with photos of weight loss, glowing testimonials and step-by-step instructions for mixing or injecting at residence.

Within minutes of entering one community, a seller posted WhatsApp details, where most purchases take place. The vendor sent an instruction manual and promised shipping within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about body mass, health issues or previous experience.

Item Information and Pricing

Within these groups, posts show dark colored packages with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with purified liquid, or ready-to-use injectors typically sold at £160 for 20 milligrams. When asked how long a pen should last, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram said it actively moderated harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering materials they can’t verify. Even if the science behind this drug is sound, these online versions may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.

Her staff has already seen patients harmed by personal administration from unverified sources. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they explained, adding that any item “falsely representing itself as a company experimental product not yet authorized … may subject users to possibly serious health risks”.